Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of Ozempic

Published on May 11, 2026

Cellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk.